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Proximal  hypospadias in a  male patient  with  5-reductase deficiency: A case 
reports 
                                                                                 Erol Basuguy, Selcuk Otcu 
Abstract  Hypospadias is a congenital disorder of male external genital. The newborn 
showed penoscrotal  hypospadias with chordee and  microphallus. Endocrine 
data and a normal male karyotype were suggestive of 5-reductase deficiency. 
Penoscrotal hypospadias repair of the patient was made. 
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Introduction 
Hypospadias is a congenital disorder of male 
external  genital  with  an  incidence  of  0.03–
0.4%.  However,  epidemiological  evidence 
suggests that in developed Western countries 
the  incidence  is  increasing  [1].  The  male 
human urethra develops in the course of fetal 
wk 8–16, and any  hesitation  in this process 
causes hypospadias. However, the etiology of 
the hypospadias is still not clearly understood 
[2].  It  may  be  categorized  as  simple 
(glandular  or  penile)  or  severe  (penoscrotal, 
scrotal  or  perineal)  according  to  the 
anatomical location of the urethral meatus [3].   
The  development  of  the  external  male 
genitalia occurs by the induction, growth and 
differentiation of the genital tubercle  by the 
effect  of  androgens  [4].  Dihydrotestosterone 
(DHT)  synthesized  by  5-reductase  is  more 
potent than  testosterone  (T)  and  is  essential 
for  normal  development of  the  human  male 
external genitalia [5]. Here, we report a boy 
with  5-reductase  deficiency  and  proximal 
hypospadias. 
Case reports 
The  newborn  showed  penoscrotal 
hypospadias  with  chordee  and  microphallus 
(2.3 cm length). Palpable gonads were located 
in the scrotum. Endocrine data and a normal 
male  karyotype  were  suggestive  of  5-
reductase  deficiency.  The  testosterone  was 
540  pg/ml  and  dihydrotestosterone  was  16 
pg/ml  and  the  basal  T:DHT  ratio  was  33. 
After  administration  of  hCG  plasma 
testosterone  was  4.58ng/ml  and   7 
dihydrotestosterone  was  22.7  pg/ml.  The 
length of the phallus increased by 5 mm (from 
2.3  to  2.8  cm)  after  administration  of 
testosterone enanthate once per month  for 3 
months.  Penoscrotal  hypospadias  of  the 
patient was repaired and in the patient did not 
develop any problems (Fig. 1).  
 
 
Figure 1. Post-operative appearance of the penis. 
 
Discussion 
The enzyme 5-reductase is an nicotinamide 
adenine  dinucleotide  phosphate  dependent 
protein  that  catalyses  the  conversion  of 
testosterone  into  DHT.    It  is  50-fold  more 
potent than testosterone 6. 
 
 
DHT  is  essential  for  formation  of  the  male 
phenotype such as the male external genitalia, 
urethra  and  prostate  during  embryogenesis 
7.  A  rare  disease,  the  enzyme  steroid  5-
reductase deficiency represents 46,XY genetic 
male  subjects  who  have  incomplete 
virilization  of  their  external  genitalia  and 
testes 8. However, the clinical spectrum is 
heterogeneous,  varying  from  a  female  to  a 
fully  male  phenotype  with  hypospadias  or 
only microphallus 9,10. Spermatogenesis is 
generally normal if the testes are descended in 
the  scrotum  11.  Hormonal  values  include 
normal or increased testosterone levels, with 
low DHT levels in relation to T and a high 
ratio  of  5β-  to  5--reduced  urinary  steroid 
metabolites.  Stimulation  with  human 
chorionic  gonadotropin  (hCG)  reveals  more 
this  altered  ratio  12.  Hypospadias  can  be 
induced experimentally by androgen receptor 
antagonists,  inhibitors  of  5-reductase,  and   8 
inhibitors  of  enzymes  involved  in  steroid 
hormone synthesis 13-15. 
Different of types of the hypospadias can be 
observed according to the original site of the 
opening of the urethral  meatus and to other 
associated  anomalies.  Proximal  hypospadias 
are a less frequently seen and correspond to 
20%  of  all  cases  of  hypospadias  16. 
Proximal hypospadias usually found together 
with chordee. Chordee is formed by residual 
fibrous tissue of the corpus spongiosum and is 
located on the ventral side of the urethra 17. 
Additionally,  proximal  hypospadias  with 
chordee  is  the  most  challenging  type  of 
hypospadias to reconstruct
18.  Complications 
of  the  hypospadias  repair  are  generally 
complete  disruption,  fistula  formation, 
stenosis,  post  operative  bleeding,  and 
recurrence  of  chordee  or  excess  skin  at  the 
glans.  The  most  common  complication  is 
fistula  formation  19.    Optimal  age  for 
hypospadias  repair  is  between  8  and  12 
months  of  age  17.  In  the  present  case, 
endocrine  data  were  followed.  Our  patient 
was operated on a year old and was used flap 
from scrotum  for repair of the  hypospadias, 
chordee was corrected. 
As  a  result,  in  patients  with  proximal 
hypospadias  and  micropenis,  endocrine  data 
should  be  obtained  and  a  multidisciplinary 
approach  to  the  treatment  of  patients  is 
important. 
CONFLICT OF INTEREST 
None declared. 
 
References 
1.  Paoluzzi  LJ.  Is.  hypospadias  an 
environmental’  birth  defect?  Dialogues 
Pediatric Urol. 2000; 23: 2–4. 
2.  Manson  JM,  Carr  MC.  Molecular 
epidemiology  of  hypospadias:  review  of 
genetic and environmental risk factors. Birth 
Defects  Res  A  Clin  Mol  Teratol.  2003; 
67:825–883. 
3. Wang Y, Li Q, Xu J, Liu Q, Wang W, Lin 
Y,  Ma  F,  Chen  T,  Li  S,  Shen  Y.  Mutation 
analysis  of  five  candidate  genes  in  Chinese 
patients with hypospadias. Eur J Hum Genet. 
2004;12:706-12. 
4.  Rey  R,  Picard  JY.  Embryology  and 
endocrinology  of  genital  development. 
Baillieres  Clin  Endocrinol  Metab 
1998;12:17–33. 
5. Kim KS, Liu W, Cunha GR, Russell DW, 
Huang H, Shapiro E, Baskin LS. Expression 
of  the  androgen  receptor  and  5  alpha-
reductase  type  2  in  the  developing  human 
fetal  penis  and  urethra.  Cell  Tissue  Res. 
2002;307:145-53. 
6. Wilson JD, Griffin JE, Russell DW. Steroid 
5 alpha-reductase 2 deficiency. Endocr Rev. 
1993;14:577-93.  
7.  Wilson  JD.  Metabolism  of  testicular 
androgens.  In:Greep  RO,  Astwood  EB,  eds. 
Handbook  of  physiology.  Vol5.  Section  7 
Washington  DC:  American  Physiological 
Society; 1975. pp. 491-508. 
8.  Forest  MG:  Diagnosis  and  treatment  of 
disorders of sexual development, in DeGroot 
LJ, and Jameson JL (Eds): Endocrinology, 4th   9 
ed.  Philadelphia,  WB  Saunders;  2001.  pp. 
1992–1993. 
9.  Carpenter  TO,  Imperato-McGinley  J, 
Boulware  SD,  Weiss  RM,  Shackleton  C, 
Griffin JE, Wilson JD. Variable expression of 
5-reductase 2 deficiency: presentation with 
male phenotype in a child of Greek origin. J 
Clin Endocrinol Metab. 1990;71:318–322. 
10.  Hiort  O,  Sinnecker  HG,  Willenbring  H, 
Lehners A, Zollner A, Struve D. Nonisotopic 
single  strand  conformation  analysis  of  5 
alpha-reductase type 2 gene for diagnosis of 5 
alpha-reductase deficiency. J Clin Endocrinol 
Metab. 1996a;81:3415–3418. 
11. McGinley JI, and Zhu YS: Androgens and 
male  physiology:  the  syndrome  of  5-
reductase  deficiency.  Mol  Cell  Endocrinol. 
2002;198: 51–59. 
12. Bahceci M, Ersay AR, Tuzcu A, Hiort O, 
Richter-Unruh  A,  Gokalp  D.  A  novel 
missense mutation of 5-alpha reductase type 2 
gene  (SRD5A2)  leads  to  severe  male 
pseudohermaphroditism  in a Turkish  family. 
Urology. 2005;66:407-10. 
13. Noriega NC, Ostby J, Lambright C, et al. 
Late  gestational  exposure  to  the  fungicide 
prochloraz delays the onset of parturition and 
causes  reproductive  malformations  in  male 
but  not  female  rat  offspring.  Biol  Reprod 
2005;72:1324–1335. 
14. Ostby J, Monosson E, Kelce WR, et al. 
Environmental  antiandrogens:  low  doses  of 
the  fungicide  vinclozolin  alter  sexual 
differentiation  of  the  male  rat.  Toxicol  Ind 
Health. 1999:15:48–64. 
15. Carmichael SL, Shaw GM, Lammer EJ. 
Environmental and genetic contributors to 
hypospadias:  a  review  of  the  epidemiologic 
evidence.  Birth  Defects  Res  A  Clin  Mol 
Teratol. 2012;94:499-510. 
16.  Arap  S,  Mitre  AI.  Penoscrotal 
hypospadias. Braz J Urol. 2000;26: 304-314.  
17. Gittes RF, McLaughlin III AP: Injection 
technique to induce penile erection. Urology. 
1974;4: 473-4. 
18. Defoor W, Wacksman J. Results of single 
staged  hypospadias  surgery  to  repair 
penoscrotal hypospadias with bifid scrotum or 
penoscrotal  transposition.  J  Urol. 
2003;170:1585-88.  
19.  Saafan  HA.  Two  Stages  repair  of 
proximal  hypospadias:  Review  of  33  cases. 
Annals of Pediatric Surgery.  2010;6: 89-92. 
 
 
© 2014 Pediatricurologycasereports.com  
All Rights Reserved
 